Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2023 17:00 ET | Source: Shape Therapeutics, Inc.; Otsuka

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce...
June 20, 2023 08:00 ET | Source: Shape Therapeutics, Inc.

ShapeTX Announces the Appointment of Adrian W. Briggs, Ph.D. As Chief Technology Officer

SEATTLE, June 20, 2023 (GLOBE NEWSWIRE) -- ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announced the appointment of Adrian W. Briggs, Ph.D. as Chief...
May 04, 2023 08:00 ET | Source: Shape Therapeutics, Inc.

ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing the Potential of Generative AI and RNA in CNS Disorders and Beyond

SEATTLE, May 04, 2023 (GLOBE NEWSWIRE) -- ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announced seven presentations from across its technology...
January 05, 2023 08:00 ET | Source: Shape Therapeutics, Inc.

ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference

SEATTLE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ShapeTX today announced Francois Vigneault, Ph.D., Co-founder and Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare...
September 12, 2022 09:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics named one of Fierce Biotech’s “Fierce 15” Companies of 2022

SEATTLE, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), the RNA technology company advancing programmable medicine, today announced that Fierce Biotech has named it as one of...
May 12, 2022 08:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics to Present Data Highlighting Advances in Its AI-Driven RNA Technology Platforms at the 2022 ASGCT Annual Meeting

SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics® Inc. the RNA technology company advancing programmable medicine, today announced new data from its RNAfix®, RNAskipTM and AAVidTM...
April 26, 2022 08:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics Welcomes Google and Stripe Veterans Gayathri Rajan, Kelly Sims to its Board of Directors

SEATTLE, April 26, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc., the RNA technology company advancing programmable medicine, today announced the addition of two new members to its board of...
January 06, 2022 08:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company creating the future of RNA technologies, today announced that Francois Vigneault, PhD.,...
November 09, 2021 08:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics Appoints David J. Huss, Ph.D., as Chief Scientific Officer and Lisa Taylor Ash, J.D., as General Counsel

SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment...
August 24, 2021 08:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

SEATTLE, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target...